Key result
Chronic intermittent myocardial ischemia activates the intrinsic regenerative potential of dormant cardiac stem cells, which stain positive for CD117 and localize near myocardial collagenous scars.
Why the study?
Stem cell therapy could be a promising therapeutic option in ischemic cardiac diseases alongside drug treatment, reperfusion, and surgical revascularization.
Observational (n=5)
No
Cardiac stem cells are present in old myocardial infarctions and can be activated by hypoxic ischemia, suggesting a potential endogenous mechanism for cardiac regeneration.
Answers are grounded in this paper and cite their sources.
Should not yet change ischemic heart disease management; hypothesis-generating for CD117+ stem cell activation in regeneration.
Stem cells represent an old niche with various new potential therapeutics. Besides drug treatment, reperfusion procedures and surgical revascularization, stem cell therapy could be a good option in ischemic cardiac diseases. A study was performed on a small group of cases who died of cardiac arrhythmia secondary to scarring myocardial infarctions. Tissue cardiac samples were taken from these cases (from the anterior and lateral wall of the left ventricle), for microscopy examination, in order to investigate the presence of cardiac stem cells (CSC). Multiple series of histological sections were also performed and examined, along with immunohistochemical analysis (IHC). The cells were identified in close contact with the residual ischemic cardiomyocytes, in the proximity of the myocardial collagenous scar, in old myocardial infarctions. They were activated by hypoxic ischemia and were influenced by the capillary microvascular density and the interstitial micro-environment conditions. In chronic intermittent ischemia they seem to turn themselves from dormant quiescent cells into activated progenitor committed cells.
No takes yet. Share an insight, caveat, or question.
Ceauşu et al. (2020) conducted an observational in Cardiac arrhythmia secondary to scarring myocardial infarctions (n=5). Chronic intermittent cardiac ischemia (post-myocardial infarction) was evaluated on Presence and activation of cardiac stem cells (CSCs) assessed by immunohistochemistry. Chronic intermittent myocardial ischemia activates the intrinsic regenerative potential of dormant cardiac stem cells, which stain positive for CD117 and localize near myocardial collagenous scars.
Synapse has enriched 10 related papers. Consider them for comparative context: